Metastatic HR + HER2 - breast cancer

Also known as: Metastatic Breast Cancer HR+, HER2- / Metastatic HR+ HER2- breast cancer / HR+ HER2- metastatic breast cancer

DrugDrug NameDrug Description
DB12001AbemaciclibA medication used to treat HR+ HER2- advanced or metastatic breast cancer.
DB12015AlpelisibAlpelisib is indicated in combination with fulvestrant to treat postmenopausal women, and men, with advanced or metastatic breast cancer. This cancer must be hormone receptor (HR)-positive, human epidermal growth factor...
DB01006LetrozoleAn aromatase inhibitor used to treat breast cancer in postmenopausal women.
DrugDrug NamePhaseStatusCount